Both are GHRH-receptor analogues that prompt the pituitary to release its own growth hormone. Sermorelin is the shorter GHRH 1-29 fragment with a very short half-life; tesamorelin is a stabilised, trans-3-hexenoyl-modified full-length GHRH(1-44) analogue that resists breakdown, is more potent, and is the one studied (and FDA-approved as Egrifta) for reducing visceral adipose tissue. Both supplied by New-U for research use only.

Q: Is tesamorelin stronger than sermorelin?

Generally yes in research terms: tesamorelin's stabilising modification gives it greater metabolic stability and a more sustained GHRH signal, producing larger and more durable IGF-1/GH effects than the short-lived sermorelin fragment. Sermorelin's advantage is that it closely mimics the body's own physiologic pulse.

Q: Which is better for fat loss research, tesamorelin or sermorelin?

Tesamorelin is the molecule with dedicated visceral-fat data — it is the GHRH analogue specifically studied and approved for reducing visceral adipose tissue. Sermorelin raises GH more broadly but lacks that targeted body-composition evidence. This is research context, not a weight-loss or human-use recommendation; both are sold research use only.

Q: Can tesamorelin and sermorelin be combined?

They act on the same GHRH receptor, so combining two GHRH analogues is redundant rather than synergistic. Researchers instead pair a GHRH analogue (sermorelin or tesamorelin) with a ghrelin-receptor agonist like ipamorelin to engage two different pathways. Research model only.

Tesamorelin and sermorelin are both GHRH analogues — they work the same upstream lever, telling the pituitary to release its own growth hormone. The difference is durability and focus: sermorelin is the short, physiologic GHRH 1-29 fragment, while tesamorelin is a stabilised, more potent molecule with dedicated visceral-fat research behind it. Both are supplied by New-U for laboratory research only — not for human use.

Same lever, different build

Sermorelin is the first 29 amino acids of GHRH — enough to activate the receptor, but it clears in minutes. Tesamorelin is a full-length GHRH(1-44) analogue with a trans-3-hexenoyl group that shields it from enzymatic breakdown, giving a stronger, longer GHRH signal. Both preserve the pituitary's somatostatin feedback, so GH stays within physiologic bounds.

Side-by-side

Sermorelin Tesamorelin Class GHRH 1-29 fragment Stabilised GHRH(1-44) analogue Receptor GHRH receptor GHRH receptor Stability / potency Short half-life, lower potency Protease-resistant, more potent & sustained Signature research area Natural GH-pulse restoration, sleep, recovery Visceral adipose tissue reduction; IGF-1 Regulatory status Formerly approved (Geref); now research compound FDA-approved as Egrifta (HIV lipodystrophy) Feedback preserved? Yes Yes Typical framing Gentle, physiologic GHRH probe Stronger, targeted GHRH probe

The visceral-fat distinction

The clearest reason to pick one over the other in research is the visceral-fat literature: tesamorelin is the GHRH analogue with dedicated data (and an FDA approval as Egrifta) for reducing visceral adipose tissue. Sermorelin raises GH more broadly but doesn't carry that targeted body-composition evidence. If the study endpoint is visceral fat or IGF-1 magnitude, tesamorelin is the molecule with the track record; if it's modelling a natural, gentle GH rhythm, sermorelin is the lighter-touch tool.

What about stacking?

Because both hit the same GHRH receptor, combining them is redundant. The productive pairing is a GHRH analogue plus a ghrelin-receptor agonist — see Ipamorelin vs Sermorelin for why two different receptors give supra-additive GH release.

Frequently Asked Questions

What is the difference between tesamorelin and sermorelin? Both are GHRH-receptor analogues. Sermorelin is the short GHRH 1-29 fragment with a brief half-life; tesamorelin is a stabilised full-length GHRH(1-44) analogue that resists breakdown, is more potent, and is the one studied (and approved as Egrifta) for visceral-fat reduction. Both research use only.

Is tesamorelin stronger than sermorelin? In research terms generally yes — its stabilising modification gives a more sustained GHRH signal and larger IGF-1/GH effects. Sermorelin's edge is closely mimicking the body's own physiologic pulse.

Which is better for fat-loss research? Tesamorelin has the dedicated visceral-fat data and approval; sermorelin raises GH more broadly without that targeted evidence. Research context only — not a weight-loss or human-use recommendation.

Can tesamorelin and sermorelin be combined? They share the GHRH receptor, so combining them is redundant. Researchers instead pair a GHRH analogue with a ghrelin-receptor agonist like ipamorelin to engage two pathways. Research model only.

Buy Tesamorelin from New-U Research Compounds

Lab-verified by Janoshik Analytical (RP-HPLC + ESI-MS), sealed vials, discreet tracked worldwide shipping. For laboratory research use only — not for human consumption.

Part of the Growth hormone secretagogue research research area — explore related compounds, guides and sources.

PRECISION. PURITY. PERFORMANCE.

Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research

Support

Ways to Pay

Shop by goal

Muscle & IGF Research

Tissue and Cellular Models

Regenerative Research

Cellular Senescence Research

Cognitive Research

Multi-Compound Blends

Shop by compound

CJC-1295 (without DAC)

Shop by region

Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

Tesamorelin vs Sermorelin: The Stabilised GHRH Analogue Against the Classic Fragment

Same lever, different build

Side-by-side

The visceral-fat distinction

What about stacking?

Frequently Asked Questions

Related Reading

From the Lab - Peptides on LinkedIn & Facebook

Research-Grade Tesamorelin & Sermorelin

Buy Tesamorelin from New-U Research Compounds